Welcome to RELISTOR

This website has been developed for all healthcare professionals who are involved in the management of palliative patients with opioid-induced constipation (OIC). Its aim is to provide information on RELISTOR, the only peripherally-acting mu-opioid receptor antagonist designed to treat the underlying cause of OIC.

Use the navigation tool to access important further information on the product and to understand how RELISTOR can be administered.